PARDES BIOSCIENCES INC's ticker is and the CUSIP is 69945Q105. A total of 1 filers reported holding PARDES BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,317 | -52.1% | 13,435 | -65.0% | 0.02% | -44.7% |
| Q1 2023 | $50,734 | -16.1% | 38,435 | +7.4% | 0.04% | -39.7% |
| Q4 2022 | $60,502 | -16.0% | 35,800 | -7.5% | 0.06% | +8.6% |
| Q3 2022 | $72,000 | -39.5% | 38,700 | 0.0% | 0.06% | -57.7% |
| Q2 2022 | $119,000 | -67.3% | 38,700 | -23.2% | 0.14% | -57.1% |
| Q1 2022 | $364,000 | +11.3% | 50,379 | +151.9% | 0.32% | +67.0% |
| Q4 2021 | $327,000 | – | 20,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Opportunity Management V, LLC | 5,227,307 | $37,741,000 | 52.85% |
| Foresite Capital Management V, LLC | 9,400,515 | $67,872,000 | 27.72% |
| Lynx1 Capital Management LP | 1,642,834 | $11,861,000 | 11.01% |
| Frazier Life Sciences Management, L.P. | 2,081,007 | $15,025,000 | 1.28% |
| RA Capital Management | 6,175,038 | $44,584,000 | 0.97% |
| Arena Capital Advisors, LLC- CA | 851,281 | $6,146,000 | 0.93% |
| DAFNA Capital Management LLC | 421,157 | $3,041,000 | 0.79% |
| Sio Capital Management, LLC | 315,564 | $2,278,000 | 0.75% |
| TCG Crossover Management, LLC | 229,100 | $1,654,000 | 0.66% |
| Altium Capital Management LP | 253,000 | $1,827,000 | 0.61% |